Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0105 USD
−2.27 M USD
73.32 M USD
171.82 M
About Somnomed Limited
Sector
Industry
Website
Headquarters
Sydney
Founded
1987
ISIN
AU000000SOM1
FIGI
BBG000Q4T7Z7
SomnoMed Ltd. engages in the production and sale of devices for the oral treatment of sleep related disorders. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux, SomTabs, and Sunrise Sleep Test. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded in 2004 and is headquartered in Sydney, Australia.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SOMNF is 0.4625 USD — it has increased by 6.05% in the past 24 hours. Watch Somnomed Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Somnomed Ltd. stocks are traded under the ticker SOMNF.
We've gathered analysts' opinions on Somnomed Ltd. future price: according to them, SOMNF price has a max estimate of 0.65 USD and a min estimate of 0.65 USD. Watch SOMNF chart and read a more detailed Somnomed Ltd. stock forecast: see what analysts think of Somnomed Ltd. and suggest that you do with its stocks.
SOMNF reached its all-time high on Jan 18, 2018 with the price of 3.1500 USD, and its all-time low was 0.0100 USD and was reached on Sep 15, 2009. View more price dynamics on SOMNF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SOMNF stock is 5.71% volatile and has beta coefficient of 1.92. Track Somnomed Ltd. stock price on the chart and check out the list of the most volatile stocks — is Somnomed Ltd. there?
Today Somnomed Ltd. has the market capitalization of 115.36 M, it has increased by 2.39% over the last week.
Yes, you can track Somnomed Ltd. financials in yearly and quarterly reports right on TradingView.
Somnomed Ltd. is going to release the next earnings report on Feb 27, 2026. Keep track of upcoming events with our Earnings Calendar.
SOMNF earnings for the last half-year are 0.00 USD per share, whereas the estimation was 0.00 USD, resulting in a −250.00% surprise. The estimated earnings for the next half-year are 0.00 USD per share. See more details about Somnomed Ltd. earnings.
Somnomed Ltd. revenue for the last half-year amounts to 38.01 M USD, despite the estimated figure of 35.84 M USD. In the next half-year revenue is expected to reach 40.12 M USD.
SOMNF net income for the last half-year is −2.20 M USD, while the previous report showed −65.29 K USD of net income which accounts for −3.27 K% change. Track more Somnomed Ltd. financial stats to get the full picture.
No, SOMNF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Somnomed Ltd. EBITDA is 3.57 M USD, and current EBITDA margin is 4.88%. See more stats in Somnomed Ltd. financial statements.
Like other stocks, SOMNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Somnomed Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Somnomed Ltd. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Somnomed Ltd. stock shows the sell signal. See more of Somnomed Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.